molecule that showed significant antidepressant properties when administered intraperitoneally
onceSmirnova, L. A.,
Spasov, A. A.,
Khaliullin, F. A.,
Kucheryavenko, A. F.,
Ryabukha, A. F.,
Abramov, O. K. (2021) in rabbit blood plasma upon intravenous
administration were compared and analyzed. The relative
Baltina, L. A.,
Sapozhnikova, T. A.,
Gabdrakhmanova, S. F.,
Makara, N. S.,
Khisamutdinova, R. Yu.,
Baltina, L. A. Jr.,
Petrova, S. F.,
Saifullina, D. R.,
Kondratenko, R. M. (2021) model after peroral
administration to male Wistar rats. It was found that GA and its conjugate IV at a
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) administration attenuates HFD-induced myocardial inflammation by inhibiting NF-κB and JNK activation in mouse
Boyko, A.N.,
Bakhtiyarova, K.Z.,
Brylev, L.V.,
Zakharova, M.N.,
Kasatkin, D.S.,
Korobko, D.S.,
Kotov, S.V.,
Krasnov, V.S.,
Malkova, N.A.,
Popova, E.V.,
Sivertseva, S.A.,
Simaniv, T.O.,
Sokolova, A.A.,
Totolyan, N.A.,
Trushnikova, T.N.,
Khabirov, F.A.,
Khachanova, N.V. (2021) mainly the optic nerves, spinal cord, and area postrema. The diagnostic capabilities,
administration